Medipure Pharmaceuticals

Medipure Pharmaceuticals is a Canadian biopharmaceutical company focused on developing cannabinoid-based prescription medicines for a variety of medical conditions. The company utilizes proprietary drug delivery technologies to optimize the therapeutic potential of cannabinoids, aiming to improve bioavailability and patient outcomes. Their research pipeline targets significant unmet needs in chronic pain management, mental health, and dermatology. By applying pharmaceutical-grade standards to cannabinoid research, Medipure seeks to provide evidence-based treatments that are both safe and effective. The company's lead programs include treatments for chronic pain and anxiety, currently in the pre-clinical stages of development.